ScholarWorks@Hanyang University: Browsing ScholarWorks

Browsing by Chu, MyronAuthor

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Sort by: In order: Results/Page Authors/Record:

Showing results 1 to 3 of 3

SCISCIESCOPUS

A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea Go to Link

Zhang, Fengchun; Bae, Sang-Cheol; Bass, Damon; Chu, Myron; Egginton, Sally; Gordon, David; Roth, David A.; Zheng, Jie; Tanaka, Yoshiya

ArticleIssue Date2018CitationAnnals of the Rheumatic Diseases, v.77, no.3, pp 355 - 363PublisherBMJ Publishing Group

A Pivotal Phase III, Randomized, Placebo-Controlled Study of Belimumab in Patients with Systemic Lupus Erythematosus Located in China, Japan, and South Korea Go to Link

Zhang, Fengchun; Bae, Sang-Cheol; Bass, Damon; Chu, Myron; Egginton, Sally; Gordon, David; Roth, David; Tanaka, Yoshiya; Zheng, Jie

ConferenceIssue Date2016Citation2016 ACR/ARHP Annual MeetingPublisherWILEYPlaceUS

SCIESCOPUS

Long-term open-label continuation study of the safety and efficacy of belimumab for up to 7 years in patients with systemic lupus erythematosus from Japan and South Korea Go to Link open access

Tanaka, Yoshiya; Bae, Sang-Cheol; Bass, Damon; Curtis, Paula; Chu, Myron; DeRose, Kathleen; Ji, Beulah; Kurrasch, Regina; Lowe, Jenny; Meizlik, Paige, et al.

ArticleIssue Date2021CitationRMD OPEN, v.7, no.2, pp.1 - 11PublisherBMJ PUBLISHING GROUP

RSS_1.0 RSS_2.0 ATOM_1.0

222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Browsing by Chu, MyronAuthor

BROWSE